Sanimed Société Anonyme

BVMT:SANIMED Stock Report

Market Cap: د.ت13.8m

Sanimed Société Anonyme Past Earnings Performance

Past criteria checks 0/6

Sanimed Société Anonyme's earnings have been declining at an average annual rate of -14.8%, while the Building industry saw earnings growing at 21.1% annually. Revenues have been growing at an average rate of 1.6% per year.

Key information

-14.8%

Earnings growth rate

-14.8%

EPS growth rate

Building Industry Growth15.1%
Revenue growth rate1.6%
Return on equity-38.4%
Net Margin-25.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sanimed Société Anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BVMT:SANIMED Revenue, expenses and earnings (TND Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2435-9110
31 Mar 2438-9110
31 Dec 2340-9110
30 Sep 2342-11120
30 Jun 2344-14130
31 Mar 2351-12130
31 Dec 2258-10130
30 Sep 2261-7130
30 Jun 2263-4140
31 Mar 2263-2140
31 Dec 21630140
30 Sep 2158-2140
30 Jun 2153-4130
31 Mar 2144-8120
31 Dec 2035-13110
30 Sep 2036-12100
30 Jun 2036-12100
31 Mar 2039-8110
31 Dec 1943-4110
30 Sep 1944-2120
30 Jun 1945-1120
31 Mar 19460120
31 Dec 18471110
31 Dec 17382100
31 Dec 1632390
31 Dec 1529380
31 Dec 1424270

Quality Earnings: SANIMED is currently unprofitable.

Growing Profit Margin: SANIMED is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SANIMED is unprofitable, and losses have increased over the past 5 years at a rate of 14.8% per year.

Accelerating Growth: Unable to compare SANIMED's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SANIMED is unprofitable, making it difficult to compare its past year earnings growth to the Building industry (20.4%).


Return on Equity

High ROE: SANIMED has a negative Return on Equity (-38.37%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 10:58
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sanimed Société Anonyme is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution